PMDS Stock Overview
A digital medical device company, develops and sells respiratory monitoring solutions in Ireland. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
My Notes
Capture your thoughts, links and company narrative
PMD Device Solutions AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.66 |
| 52 Week High | SEK 112.64 |
| 52 Week Low | SEK 0.52 |
| Beta | 0 |
| 1 Month Change | -51.47% |
| 3 Month Change | -78.15% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -94.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| PMDS | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | 8.2% | 1.2% | -2.7% |
| 1Y | n/a | 13.8% | 4.6% |
Return vs Industry: Insufficient data to determine how PMDS performed against the Swedish Biotechs industry.
Return vs Market: Insufficient data to determine how PMDS performed against the Swedish Market.
Price Volatility
| PMDS volatility | |
|---|---|
| PMDS Average Weekly Movement | 19.2% |
| Biotechs Industry Average Movement | 9.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.4% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: PMDS's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: PMDS's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 29 | Myles Murray | www.pmd-solutions.com |
PMD Device Solutions AB, a digital medical device company, develops and sells respiratory monitoring solutions in Ireland. The company offers RespiraSense, a solution used for monitoring respiratory rate to support the early detection of patient deterioration, and avoid preventable respiratory failure and adverse patient outcomes; RespiraSense Air, which enables remote monitoring of any ward; and EWS, which uses the RespiraSense Air telemetry system to connect addition wireless peripheral sensors for high-risk patients. It also provides virtual ward services, such as 24/7 video support, technology management, reporting, digital inclusivity, secondary monitoring, and end-to-end management from the patient’s admission to discharge.
PMD Device Solutions AB Fundamentals Summary
| PMDS fundamental statistics | |
|---|---|
| Market cap | SEK 17.12m |
| Earnings (TTM) | -SEK 47.65m |
| Revenue (TTM) | SEK 39.12m |
0.4x
P/S Ratio-0.4x
P/E RatioIs PMDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMDS income statement (TTM) | |
|---|---|
| Revenue | SEK 39.12m |
| Cost of Revenue | SEK 8.68m |
| Gross Profit | SEK 30.43m |
| Other Expenses | SEK 78.09m |
| Earnings | -SEK 47.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | -1.84 |
| Gross Margin | 77.80% |
| Net Profit Margin | -121.82% |
| Debt/Equity Ratio | -23.9% |
How did PMDS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:01 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PMD Device Solutions AB is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Johan Unnerus | Redeye |